Axicabtagene ciloleucel in relapsed or refractory large B-cell lymphoma patients in complete metabolic response-Reference-Cited by-同舟云学术

Axicabtagene ciloleucel in relapsed or refractory large B-cell lymphoma patients in complete metabolic response

Published:2022-11-17 Issue:4 Volume:108 Page:1163-1167
ISSN:1592-8721
Container-title:Haematologica
language:
Short-container-title:haematol

Author:

Jallouk Andrew P.,Gouni Sushanth,Westin Jason,Feng Lei,Mistry Haleigh,Steiner Raphael E.,James Jinsu,Noorani Mansoor,Horowitz Sandra,Puebla-Osorio Nahum,Fayad Luis E.,Iyer Swaminathan P.,Hawkins Misha,Flowers Christopher R.,Ahmed Sairah,Nastoupil Loretta J.,Kebriaei Partow,Shpall Elizabeth J.,Neelapu Sattva S.,Nieto Yago,Strati Paolo

Publisher

Ferrata Storti Foundation (Haematologica)

Subject

Hematology

Reference14 articles.

1. Locke FL, Miklos DB, Jacobson CA. Axicabtagene ciloleucel as second-line therapy for large B-cell lymphoma. N Engl J Med. 2022; 386(7):640-654.

2. Neelapu SS, Locke FL, Bartlett NL. Axicabtagene ciloleucel CAR T-cell therapy in refractory large B-cell lymphoma. N Engl J Med. 2017; 377(26):2531-2544.

3. Johnston PB, Wiseman GA, Micallef IN. Positron emission tomography using F-18 fluorodeoxyglucose pre- and post-autologous stem cell transplant in non-Hodgkin's lymphoma. Bone Marrow Transplant. 2008; 41(11):919-925.

4. Filmont JE, Gisselbrecht C, Cuenca X. The impact of preand post-transplantation positron emission tomography using 18-fluorodeoxyglucose on poor-prognosis lymphoma patients undergoing autologous stem cell transplantation. Cancer. 2007; 110(6):1361-1369.

5. Svoboda J, Andreadis C, Elstrom R. Prognostic value of FDG-PET scan imaging in lymphoma patients undergoing autologous stem cell transplantation. Bone Marrow Transplant. 2006; 38(3):211-216.

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Outcomes of patients with R/R B-cell NHL and limited (<5 sites) pre-CART disease bridged with or without radiotherapy;Blood Advances;2024-09-24

2. Autologous transplant vs. CAR-T therapy in patients with DLBCL treated while in complete remission;Blood Cancer Journal;2024-07-08

3. Role of radiation in chimeric antigen receptor T-cell therapy for patients with relapsed/refractory non-Hodgkin lymphoma: Current studies and future prospects;Critical Reviews in Oncology/Hematology;2024-07

4. Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Is There Still a Role for Autologous Stem Cell Transplantation in the CAR T-Cell Era?;Cancers;2024-05-23

5. Chimeric antigen receptor T-cell infusion for large B-cell lymphoma in complete remission: a center for international blood and marrow transplant research analysis;Leukemia;2024-05-15